Stents having bioabsorable layers

1. A device comprising:

a. a substrate consisting essentially of layers of polymer and layers of pharmaceutical agent;

b. a plurality of layers deposited directly on said substrate, wherein a first layer comprises a first bioabsorbable polymer, a second layer comprises a layer of a first pharmaceutical agent, a third layer comprises a second bioabsorbable polymer, a fourth layer comprises a layer of said first pharmaceutical agent, and a fifth layer comprises a third bioabsorbable polymer,

wherein said device has a first pharmaceutical agent content of about 1 μg/mm to about 15 μg/mm, and

wherein at least a portion of the first pharmaceutical agent is in crystalline form.

2. The device of claim 1 , wherein said first, second, and third bioabsorbable polymers comprise the same bioabsorbable polymer.

3. The device of claim 1 , wherein said first, second, and third bioabsorbable polymers comprise different bioabsorbable polymers.

4. The device of claim 1 , wherein 5% to 25% of the first pharmaceutical agent is eluted one day after the device is contacted with elution media.

5. The device of claim 1 , wherein 15% to 45% of the first pharmaceutical agent is eluted 7 days after the device is contacted with elution media.

6. The device of claim 1 , wherein 25% to 60% of the first pharmaceutical agent is eluted 14 days after the device is contacted with elution media.

7. The device of claim 1 , wherein 35% to 70% of the first pharmaceutical agent is eluted 21 days after the device is contacted with elution media.

8. The device of claim 1 , wherein said substrate comprises a stent.

9. The device of claim 1 , wherein said first pharmaceutical agent comprises an antiproliferative agent.

10. The device of claim 7 , wherein said antiproliferative agent is a limus drug or paclitaxel.